Velcade, Vidaza, Vistide fall foul of Ben Venue closure
This article was originally published in Scrip
Executive Summary
Fearing contamination, the EMA is recalling batches of Takeda's Velcade (bortezomib), Celgene's Vidaza(5-azacitidine) and Pierre Fabre's Busilvex (busulfan) manufactured at the beleaguered Ben Venu site in Ohio. The facilities are now temporarily closed while Ben Venue reviews the situation.